ArticleThe New England journal of medicine2018

Correction to our Letter to the Editor about "CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer".

Robert R J Coebergh van den Braak et al.PubMed ↗Publisher ↗

No numbers read from the abstract.